News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Yamanouchi Pharmaceutical Co., Ltd. Terminates Marketing Agreement With Daiichi Suntory Pharma Co., Ltd.


10/19/2005 5:12:46 PM

Tokyo (JCNN) - Yamanouchi Pharmaceutical Co., Ltd. (TSE: 4503) has announced that is has agreed with Daiichi Suntory Pharma Co., Ltd. (TSE:) to terminate a marketing agreement between the two companies regarding the penem-type antibiotic Farom (faropenem sodium) on March 31, 2005.

Read at JCN Newswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES